search
Back to results

Turkish of the SARS-CoV-2 Anxiety Scale

Primary Purpose

Anxiety, SARS-CoV Infection

Status
Unknown status
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
survey work
Sponsored by
DILEK SAYIK
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Anxiety focused on measuring Coronavirus Anxiety Scale, COVID-19, Anxiety

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesAccepts Healthy Volunteers

inclusion criteria;

  • individuals agree to participate in the study
  • 18 years old,
  • Lack of visual obstacle,
  • Knowing how to speak, read and write in Turkish.

Exclusion criteria;

  • individuals refuse to participate in the study
  • 18 years old,
  • Visually impaired,
  • Does not know how to speak, read and write in Turkish

Sites / Locations

  • Eskisehir Osmangazi UniversityRecruiting

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

volunteer group

Arm Description

Only volunteer participants will be included in the research. Survey forms will be sent to individuals online. Individuals who agree to participate in the study will fill in the questionnaire and send it back online.

Outcomes

Primary Outcome Measures

Anxiety in SARS-CoV-2
anxiety increase in SARS-CoV-2 in humans.
Ratio of SARS-CoV-2 anxiety scale to beck anxiety scale
The ratio of SARS-CoV-2 anxiety scale to beck anxiety scale is similar.

Secondary Outcome Measures

Full Information

First Posted
July 25, 2020
Last Updated
December 22, 2020
Sponsor
DILEK SAYIK
search

1. Study Identification

Unique Protocol Identification Number
NCT04490473
Brief Title
Turkish of the SARS-CoV-2 Anxiety Scale
Official Title
Turkish Validity And Reliability of the SARS-CoV-2 Anxiety Scale
Study Type
Interventional

2. Study Status

Record Verification Date
December 2020
Overall Recruitment Status
Unknown status
Study Start Date
July 24, 2020 (Actual)
Primary Completion Date
March 24, 2021 (Anticipated)
Study Completion Date
April 24, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
DILEK SAYIK

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The coronavirus outbreak has adversely affected individuals in the community, as in the rest of the world. However, in order to carry out this epidemic period in a healthy and conscious manner, determining the anxiety levels of individuals in the society and supporting them psychologically is of great importance. In order to achieve this, healthcare professionals working clinically or academically have important duties. This study was planned to test its validity and reliability in order to adapt the Coronavirus Anxiety Scale to Turkish.
Detailed Description
Coronaviruses can be seen in animals and humans as infections that can be mild and severe in society. The SARS-CoV-2 virus, a type of coronavirus, started in China in December 2019 and has spread worldwide as of January 2020. The absence of vaccine and treatment for SARS-CoV-2 disease threatens health worldwide and significantly affects people's daily routine. In China, where the pandemic started, shopping malls and schools were closed for a while, and city entrances and exits were stopped for a while. Although there are similar practices in excellence, as in many countries, measures such as curfew, nursery and school closure continue to be taken for under-20s and over-65s. . The coronavirus epidemic that affects our entire life is not fully known about the disease process, WHO is defined as the pandemic of the epidemic, the nearest contact is the greatest risk of transmission, and the loss of many lives during this process affects all individuals in the society negatively and increases the level of anxiety . It is a psychological reaction involving many emotions such as anxiety, stress, or anxiety, fear and distress that arise in a situation that threatens the safety of the individual. Conditions such as uncertainty, various diseases (cancer, epidemic, etc.) and losing a relative can cause anxiety. Outbreaks that occur suddenly and are at risk of death are among these reasons.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anxiety, SARS-CoV Infection
Keywords
Coronavirus Anxiety Scale, COVID-19, Anxiety

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
This research will be conducted in a methodological manner in order to conduct the validity and reliability studies of the Coronary Virus Anxiety Scale in Turkish.
Masking
None (Open Label)
Allocation
N/A
Enrollment
300 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
volunteer group
Arm Type
Other
Arm Description
Only volunteer participants will be included in the research. Survey forms will be sent to individuals online. Individuals who agree to participate in the study will fill in the questionnaire and send it back online.
Intervention Type
Other
Intervention Name(s)
survey work
Intervention Description
Survey forms will be sent to individuals online. Information about the study will be given to individuals with the informative text at the beginning of the questionnaire form. Individuals who agree to participate in the study will fill in the questionnaire and send it back online.
Primary Outcome Measure Information:
Title
Anxiety in SARS-CoV-2
Description
anxiety increase in SARS-CoV-2 in humans.
Time Frame
4 weeks
Title
Ratio of SARS-CoV-2 anxiety scale to beck anxiety scale
Description
The ratio of SARS-CoV-2 anxiety scale to beck anxiety scale is similar.
Time Frame
4 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
inclusion criteria; individuals agree to participate in the study 18 years old, Lack of visual obstacle, Knowing how to speak, read and write in Turkish. Exclusion criteria; individuals refuse to participate in the study 18 years old, Visually impaired, Does not know how to speak, read and write in Turkish
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
DILEK SAYIK
Phone
5065416642
Email
dileksayik@hotmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
DENIZ YIGIT
Phone
05428092848
Email
yigitdenizyigit@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
DILEK SAYIK
Organizational Affiliation
ESKISEHIR OSMANGAZI UNIVERSTY
Official's Role
Principal Investigator
Facility Information:
Facility Name
Eskisehir Osmangazi University
City
Eskisehir
Country
Turkey
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
AYFER AÇIKGÖZ
Phone
05352919374

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
It is planned to be published in the journal after the study is completed. The study will be shared with other researchers after it is published in the journal.
IPD Sharing Time Frame
will be shared after the work is finished.
IPD Sharing Access Criteria
It will be shared with researchers who want to use the anxiety scale.
Citations:
Citation
Benli, S. S., & Yıldırım, A. (2017). Hemşirelerde yaşam doyumu ve ölüme karşı tutum arasındaki ilişki. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, 6(4), 167-179
Results Reference
background
PubMed Identifier
3204199
Citation
Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988 Dec;56(6):893-7. doi: 10.1037//0022-006x.56.6.893. No abstract available.
Results Reference
background
PubMed Identifier
32099716
Citation
Chen P, Mao L, Nassis GP, Harmer P, Ainsworth BE, Li F. Coronavirus disease (COVID-19): The need to maintain regular physical activity while taking precautions. J Sport Health Sci. 2020 Mar;9(2):103-104. doi: 10.1016/j.jshs.2020.02.001. Epub 2020 Feb 4. No abstract available.
Results Reference
background
PubMed Identifier
31967327
Citation
Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020 Apr;92(4):418-423. doi: 10.1002/jmv.25681. Epub 2020 Feb 7. Erratum In: J Med Virol. 2020 Oct;92(10):2249.
Results Reference
background
PubMed Identifier
31558161
Citation
Faraji A, Karimi M, Azizi SM, Janatolmakan M, Khatony A. Occupational stress and its related demographic factors among Iranian CCU nurses: a cross-sectional study. BMC Res Notes. 2019 Sep 27;12(1):634. doi: 10.1186/s13104-019-4674-5.
Results Reference
background
PubMed Identifier
32299304
Citation
Lee SA. Coronavirus Anxiety Scale: A brief mental health screener for COVID-19 related anxiety. Death Stud. 2020;44(7):393-401. doi: 10.1080/07481187.2020.1748481. Epub 2020 Apr 16.
Results Reference
background

Learn more about this trial

Turkish of the SARS-CoV-2 Anxiety Scale

We'll reach out to this number within 24 hrs